{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-177650","form_type":"8-K","ticker":"CTMX","cik":"0001501989","company_name":"CytomX Therapeutics, Inc.","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.944679+00:00","generated_at":"2026-06-25T00:21:33.066307+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"CytomX shareholders elect McCarthy and Mohindru as directors, ratify E&Y, approve exec comp","bullets":["Class I directors Sean McCarthy and Mani Mohindru elected with ~68% of votes cast.","Ratification of Ernst & Young as auditor for FY2022 passed with 99.95% of votes cast.","Non-binding advisory vote on named executive officer compensation approved with ~93% support.","All proposals passed; broker non-votes recorded for directors and say-on-pay only."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-177650","json":"https://secwatch.observer/filing/0001193125-22-177650.json","markdown":"https://secwatch.observer/filing/0001193125-22-177650.md","text":"https://secwatch.observer/filing/0001193125-22-177650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501989/000119312522177650/0001193125-22-177650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501989/000119312522177650/d331581d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:21:33.066307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}